Everest Medicines to Announce Full-Year 2024 Financial Results on March 26, 2025

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its financial results for the full year of 2024 ended December 31, 2024, and provide a business update on March 26, 2025. The Company will hold…

Read More

Standard Chartered Earns Nearly $1 Billion in Annual Sustainable Finance Income

International banking group Standard Chartered announced that it achieved $982 million income generation from sustainable finance in 2024, growing by 36% year-over year. Announced with the release of the bank’s 2024 annual report, the growth in sustainable finance income brings Standard Chartered within reach of its goal to reach $1 billion in annual income from…

Read More